$VERU
看空2022-04-11各周期结果✓ 命中-14.1%
1d
…
5d
✓ -10.2%
21d
✓ -14.1%
原帖
Andy Biotech · 2022-04-11
For those chasing $VERU at >$1B valuation, be careful: 1) MoA (tubulin inhibitor) is not validated for #COVID19 or ARDS 2) Very small sample size: N~150 vs. other COVID19 pivotal trials (most N>1,000) 3) CEO has a long history of touting questionable data
在 X 查看 ↗